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The increasingly limited therapeutic options for the treatment of infections caused by multi-resistant
Gram-negative bacteria due to the alarming increase in bacteria resistance, renewed interest in photo-
dynamic inactivation (PDI) of bacteria. We address PDI of multi-resistant bacteria with a new family of
cationic tetra-imidazolyl phthalocyanines bearing a diversity of cationizing alkylic chain sizes, degrees of
cationization and coordinating metals. The antimicrobial activities of the phthalocyanines under white
light against Gram-positive and Gram-negative bacteria have remarkable differences in efﬁcacy. We
relate their spectroscopic and photophysical properties with the generation of reactive oxygen species
(ROS), biological performance and structural features. We show that sub-micromolar concentrations of a
Zn(II) tetra-ethyl cationic phthalocyanine reduce colonies of Gram-negative bacteria (E. coli,
P. aeruginosa) and C. albicans by 7 log units while leaving mammalian cells unharmed. This is a new lead
to address hard-to-treat localized infections.
© 2019 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
The increase of bacteria multi-drug resistance is becoming a
major social threat and a growing economic burden to healthcare
systems [1]. According to a recent WHO report [2,3], the number of
infection-related deaths caused by multi-resistant microorganisms
is likely to steadily increase and is projected to reach 10 million
deaths/year worldwide by 2050. New classes of antibiotics effective
against Gram-positive bacteria were recently discovered [4], butn; CFU, colony forming unit;
ydroethidium; DMAE, dime-
DMSO, dimethyl sulfoxide;
yphenyl) ﬂuorescein; MTT, 3-
bromide; PBS, phosphate
hotosensitizer; ROS, reactive
FD, singlet oxygen quantum
te), jdabrows@chemia.uj.edu.
r Masson SAS. This is an open acceprogress regarding control of infections by Gram-negative bacteria
is unsatisfactory [5]. Moreover, the increasing ability of bacteria to
acquire resistance to conventional antibiotics, especially when they
have one single target in the cell, recommends exploring thera-
peutic approaches that are less prone to resistance [6,7]. Among
them, photodynamic inactivation (PDI) of bacteria [8e12] has
already provided good examples of efﬁcient inactivation of multi-
drug resistant strains of S. aureus, P. aeruginosa, E. coli and
A. baumannii [13,14]. PDI combines a photosensitizer molecule, a
light source and molecular oxygen to generate reactive oxygen
species (ROS), namely 1O2, O2-, H2O2 and HO. These ROS produce
oxidative stress in microorganisms that trigger various mecha-
nisms of action eventually leading to cell death [11,15e18]. PDI is a
multi-targeted approach because ROS react with a wide range of
biomolecules. In particular, singlet oxygen generated inside a bac-
terium can explore all of its size and react anywhere in the cell [19].
It is now accepted that, compared to classical antibiotic therapies,
PDI-treated bacteria are less prone to development of multidrug
resistance (MDR) [15,20e23].
It is recognized that Gram-positive bacteria aremore susceptible
to PDI, but the factors that govern that susceptibility are not yetss article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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guide the design and development of better antimicrobial photo-
sensitizers, capable of inactivating Gram-positive bacteria and also
the very challenging Gram-negative bacteria. Gram-negative bac-
teria that are amongst the most frequent cause of nosocomial in-
fections and of infections in immunosuppressed patients [24]. The
difﬁculty to kill Gram-negative bacteria is largely due to presence of
an outer membrane that serves as a highly impermeable barrier to
antibiotics. The presence of lipopolysaccharides in the outer
membrane of Gram-negative bacteria may also induce the release
of pro-inﬂammatory cytokines from host cells and can act as a
potent virulence factor. Another important virulence factor is the
ability to secrete proteases which can degrade the matrix proteins
impairing tissue integrity as well as disrupt defence systems such
as antibodies or cytokines [24]. Moreover, many of Gram-negative
bacteria (e.g. P. aeruginosa) contain endotoxins that are able to
block potential drugs and protect the sensitive inner membrane
and cell wall [25]. Rationally designed photosensitizers may
contribute to surmount these obstacles and overcome drug-
resistance mechanisms of traditional antibiotic therapy [20,26].
Phthalocyanines were shown to be efﬁcient photosensitizers in
the photodynamic inactivation of microorganisms [12] as well as in
photodynamic therapy of cancer [27]. Cationization and metalation
of photosensitizers improved PDI of microorganisms [7,28,29]. For
instance, cationic zinc pyridinium phthalocyanine [30] and cationic
N-methylpyridinium porphyrins [31] were among the examples of
photosensitizers capable of photoinactivating both Gram-negative
and Gram-positive bacteria. These pioneer studies helped to
realize that effective PDI of Gram-negative bacteria required a
photosensitizer with a pronounced cationic charge. The quest for
cationic photosensitizers with stronger light absorption in the
near-infrared motivated the development of cationic chlorins
[32,33], bacteriochlorins [34,35], porphycenes [36] and phthalo-
cyanines [37,38], and the characterization of their PDI effect. Zn(II)
cationic anilinium phthalocyanines are among the best examples of
cationic metallophthalocyanines: 0.1 mM concentrations and 5min
irradiation with 600e700 nm light (50mW/cm2) led to a 5 logs
reduction of S. aureus colonies [39]. Although the inactivation of
Gram-negative bacteria is more challenging, PDI using phthalocy-
anines with different structural motifs were reported [40e48]. Dei
et al. used cationic phthalocyanines bearing trialkylammonium
groups and were able to reduce E. coli colonies by 6 log units with
1 mM photosensitizer concentration and red light irradiation
(50mW/cm2) for 10min [49]. Cationic phthalocyanines can also
inactivate fungi [50e53]. The family of phthalocyanines mentioned
above achieved a 6 log reduction of C. albicans at photosensitizer
concentrations of 1 mM under red light irradiation (50mW/cm2) for
10min [49].
A good disinfection consists in decreasing the number of bac-
teria colonies by 5 or 6 log units. The photosensitizers currently
employed in PDI require micromolar concentrations to meet this
goal [54]. Attempts to increase the potency of phthalocyanines for
PDI should consider the following factors: i) adding cationic groups
to increase electrostatic interaction with the outer membrane im-
proves PDI of Gram-negative bacteria and increases hydrophilicity
[8,49]; ii) increasing of the size of cationizing alkyl chain favours
photosensitizer uptake [50] and may result in enhanced antimi-
crobial activity [55,56]. The role of differences in cell wall thickness
between Gram-positive and Gram-negative bacteria (20e80 nm for
Gram-positive bacteria and 10e15 nm for Gram-negative species)
was investigated using crystal violet-based photosensitizers. The
depth of the modiﬁed derivative in the bacterial cell walls plays a
key role in its PDI selectivity, which in turns is controlled by the
positive charges of the photosensitizer [57]. It must be realized that
PDI in vivo adds the problem that increased phototoxicity is oftencorrelated with damage to normal tissue [58], and is still unclear
how to favour PDI of microorganisms without phototoxicity to-
wards human cells. Structure-activity relationships and formula-
tions for PDI must also consider cytotoxicity towards eukaryotic
cells.
It came to our attention that imidazole-containing metal-
lophthalocyanines showed good photosensitizing results towards
cancer cells [59], but their use in PDI of bacteriawas overlooked.We
decided to synthesise a new family of imidazole-substituted Zn(II)
and Al(III) phthalocyanines with a different number of positive
charges and cationizing alkyl chain of different lengths. We studied
the inﬂuence of these structural modiﬁcations on uptake and PDI of
microbial cells, as well as their toxicity towards human cells. The
photosensitizers photophysical and photochemical properties, and
their ROS generation efﬁcacy in biological media were character-
ized. Their uptake was also investigated by confocal laser scanning
microscopy and correlated with PDI activity. We succeeded, for the
ﬁrst time, to reduce by 7 logs units the number of colonies of two
Gram-negative bacteria (E. coli and P. aeruginosa) using nanomolar
photosensitizer concentrations under conditions of negligible
phototoxicity towards human cells.
2. Results and discussion
Synthesis. The cationic phthalocyanines used in this study were
synthesized according to Scheme 1. 4-(1H-Imidazol-1-yl)phthalo-
nitrile 1was prepared by reacting commercial 4-nitrophthalonitrile
with imidazole in DMF, at room temperature, in the presence of
K2CO3, and was isolated in 56% yield. The cyclotetramerization re-
action of phthalonitrile 1 and Zn(II) acetate was performed in
dimethylaminoethanol (DMAE) at 140 C for 48 h. The corre-
sponding Al(III) phthalocyanine, was obtained by adding AlCl3 to
phthalonitrile 1 in 1-chloronaphthalene and reacting at 240 C for
6 h. After precipitation of the product from the reaction medium
and puriﬁcation by consecutive washing using solvents with
increasing polarities (dichloromethane, acetone, methanol and
water), the corresponding tetra-imidazole b-substituted metal-
lophthalocyanines 2 and 3 were isolated in 71% and 60% yields,
respectively. The products, and in particular 2, showed poor solu-
bility in most organic solvents, except in DMF, DMSO and pyridine.
This is likely to be caused by p-p stacking. However, compounds 2
and 3 were readily soluble in protic solvents at acidic pH, as ex-
pected, given the basic properties of imidazole group. Satisfactory
1H NMR spectra of non-protonated dye 2 could only be obtained in
pyridine-d5 at 80 C, as previously described for other planar
phthalocyanines [60].
Reaction of 2 with iodoethane or iodooctane in DMF yielded
tetra-cationic Zn(II) phthalocyanines with varied degrees of lip-
ophilicity, 2a and 2b, respectively, which were isolated by direct
precipitation from the reaction mixture by adding CH2Cl2 or diethyl
ether, respectively. The octa-cationic phthalocyanine 2c was ob-
tained by reaction of 2 with commercial (2-chloroethyl)trimethy-
lammonium chloride. This strategy improved signiﬁcantly the
synthesis of octa-cationic phthalocyanines, when compared with
an earlier report involving synthetically demanding routes [44,49].
Compared with 2a and 2b, the synthesis of 2c required the use of
potassium iodide as catalyst and increased reaction time and
temperature, to overcome for lower reactivity of the chloroalkyl-
ammonium salt. The crude product was obtained by direct pre-
cipitation from the reaction mixture with CH2Cl2, followed by
washing with ethanol. Further puriﬁcation using gel permeation
chromatography ensured the removal of the unreacted ionic re-
agent. The 1H NMR spectrum of 2c in DMSO‑d6 showed small broad
signals, regardless of its concentration and addition of D2O, which
were ascribed to aggregation. Elemental analysis indicated traces of
Scheme 1. Synthetic procedure used to obtain the cationic Zn(II) and Al(III) phthalocyanines.
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reports on KI mediated enhancement of PDI [61]. Al(III) tetra-ethyl
cationic phthalocyanine 3a was synthesized by reacting 3 with
iodoethane using a protocol identical to that used to obtain 2a.
Electronic absorption and emission measurements. All the
metallophthalocyanines showed UVeVis spectra in DMSO typical
of this class of compounds in monomeric form, with a Soret band
(300e400 nm) and a Q band centred at 682 nm for 2, 677 nm for
2a-c, 693 nm for 3 and 680 nm for 3awhich also showed a satelliteFig. 1. Normalized UVeVis absorption spectra. (a) Zn(II) metallophthalocyanines (2 and 2a-
cationic metallophthalocyanines (2a, 2c and 3a) in H2O.band corresponding to a vibronic transition (Fig. 1a and b). The blue
shift of 2a-c relative to 2 is likely to result from the reduced
electron-donating ability of the quaternized imidazole group. Ab-
sorption spectra in H2O revealed different extents of aggregation.
The polar axial ligand OH in 3a seems to prevent aggregation
because the spectra in water and DMSO are almost identical and
characteristic for monomeric species. The spectrum of octa-cationic
phthalocyanine 2c in H2O shows a small increase of the 612 nm
band, a consequence of exciton coupling due to formation of dimersc) in DMSO; (b) Al(III) metallophthalocyanines (3 and 3a) in DMSO; (c) water-soluble
R.T. Aroso et al. / European Journal of Medicinal Chemistry 184 (2019) 1117404in solution [60]. On the other hand, the 616 nm band of 2a is
signiﬁcantly increased, revealing more extensive aggregation. The
electrostatic repulsion between positively charged moieties in 2c is
effective in reducing p-p stacking. Data for 2b is not provided
because its solubility in aqueous media is too low to obtain
meaningful spectra, as expected from its increased lipophilicity.
The absorption coefﬁcients of the bands are summarized in Table 1
and are typical for metallophthalocyanines [27,62,63].
The ﬂuorescence spectra of these phthalocyanines in DMSO is
characterized by intense bands with maxima at 691 nm for 2,
687 nm for 2a-c, 702 nm for 3 and 691 nm for 3a which also has
small vibronic band. The ﬂuorescence is a good mirror image of the
absorption as expected for rigid and planar macrocycles with
negligible structural changes between ground and excited singlet
states.
Fluorescence excitation spectra in DMSO are similar to the
corresponding absorption spectra. This corroborates the absence of
contamination with free-base phthalocyanines in our samples.
However, the ﬂuorescence excitation and absorption of water-
soluble phthalocyanines, recorded in aqueous media, showed
marked differences (Fig. 2b). No ﬂuorescence emission was asso-
ciated with absorption band at 630e640 nm. This corroborates the
assignment of this band to dimers. The ﬂuorescence excitation peak
corresponds to the absorption band at 677 nm, assigned to the
monomer, which means only monomeric species are ﬂuorescent in
solution. This is expected because radiative decay of the dimers
from their lowest energy excited state to the ground state is a
forbidden transition. All Zn(II) and Al(III) metal complexes have
moderate values of FF, which is in accordance to the values ob-
tained by other authors [62].
Singlet oxygen generation. Singlet oxygen is one of the most
signiﬁcant PDI effectors. Its production relies, among other factors,
on the ability of the photosensitizer to intersystem crossing from
the singlet excited state, prepared by electronic excitation, to a
long-lived triplet state. Diamagnetic metal complexes, namely
those with Zn(II) and Al(III), do not have metal-to-ligand charge
transfer states with energies between the HOMO and LUMO of the
macrocycles that could quickly deactivate ligand p,p* states.
Moreover, Al(III) and, especially, Zn(II) provide internal heavy-atom
effects that accelerate intersystem crossing to the triplet state.
Hence, by design, these complexes can have long-lived triplet states
formed with high quantum yields, which are ideal for singlet oxy-
gen generation [65].
Singlet oxygen quantum yields were determined in DMSO using
time-dependent singlet oxygen phosphorescence emission at
1270 nm (Table 2). ZnPc (FD¼ 0.67) was used as standard [64]. As
expected [66], all zinc metallophthalocyanines have highFD values,
while the aluminium complexes have markedly lower FD. The in-
termediate yield of compound 2 is likely a consequence of its ag-
gregation in the DMSO.
ROS generation in aqueous medium. The generation of otherTable 1
Photophysical properties of metallophthalocyanines determined in DMSO.
Phthalocyanine Absorption ε/M1 cm1 (l/nm)
2 - (358), - (616), - (682)b
2a 7.4$104 (354), 4.4$104 (611), 2.8$105 (677)
2b 6.2$104 (354), 3.7$104 (611), 2.4$105 (677)
2c 5.5$104 (343), 3.6$104 (612), 2.6$105 (677)
3 7.0$104 (364), 3.5$104 (624), 1.8$105 (693)
3a 7.0$104 (357), 3.0$104 (616), 1.7$105 (680)
a Std. FF (ZnPc)¼ 0.18 (DMSO) [64]. Values determined in the concentration range of
b Due to low solubility of the compound, no reliable values for ε were obtained.ROS, most notably hydroxyl radicals, was evaluated in aqueous
medium using aminophenyl ﬂuorescein (APF), hydroxyphenyl
ﬂuorescein (HPF) and dihydroethidium (DHE) (Fig. 3) [54]. Singlet
oxygen sensor green (SOSG) was also employed for comparison
with singlet oxygen phosphorescence measurements.
Using APF and HPF as measures of hydroxyl radical generation,
compound 2bwas the most efﬁcient generator of hydroxyl radicals
(Fig. 3a and b). Taking the redox-sensitive probe DHE as a measure
of the relative generation of superoxide ions (Figure 3d), 2bwas the
least efﬁcient in this regard. Singlet oxygen sensor green was less
discriminative than singlet oxygen phosphorescence to rank the
efﬁciency in singlet oxygen generation (Fig. 3c), but 3a yielded the
lowest amount of singlet oxygen, consistent with Table 2.
The response of the ﬂuorescent probes suggests that these
phthalocyanines are likely to undergo both Type I and Type II
mechanisms. Singlet oxygen quantum yields are highest for 2b, but
its ability to generate ROS that oxidize DHE is the lowest. Inter-
estingly, 3a has the opposite behaviour: it is the worst generator of
singlet oxygen but induced the highest ﬂuorescence of DHE.
Cationic photosensitizers are expected to interact strongly with
Gram-negative. It is likely that tightly bound photosensitizers
generate larger amount of ROS leading to more efﬁcient killing. A
word of caution must be said on the possible dependence of the
photochemical mechanisms of ROS generation on the biological
environment: blood, serum or tissue infection may favour different
mechanisms [67].
Log POW determination. Another factor that contributes to the
uptake of a photosensitizer by microbial cells is its lipophilicity,
which can be assessed by n-octanol:water partition coefﬁcients
(POW). POW values were obtained using the shake-ﬂask method and
are summarized in Table 3 in terms of their logarithmic values (log
POW). The investigated phthalocyanines cover a wide range of lip-
ophilicities. The higher lipophilicity of 2b is related to its long alkyl
chains. This may improve uptake and overall efﬁciency due to the
enhanced interaction with biological membranes. The other pho-
tosensitizers are more hydrophilic, especially 2awhich is of smaller
size. However, it was shown that photosensitizers do not have to
cross the cell envelope of Gram-negative bacteria to be phototoxic
[68], since the diffusion length of singlet oxygen in water is longer
than the width of the cell envelope [69]. Photosensitizers electro-
statically attached to the outer membrane of bacteria may also be
efﬁcient PDI photosensitizers.
Photosensitizer uptake by microorganisms. We assessed the
uptake of cationic photosensitizers 2a-c and 3a by Gram-positive
(E. faecalis and S. aureus) and Gram-negative (E. coli and
P. aeruginosa) bacteria, and fungi (C. albicans) (Fig. 4aee). The long
alkyl chains in the cationic phthalocyanine 2b led to signiﬁcantly
higher uptake in all tested microorganisms, as in earlier work
[51,55,56]. This is reﬂected in the higher log POW of 2b. The uptake
of 2a is higher for fungi (C. albicans) and for Gram-positive bacteria
(E. faecalis and S. aureus) than for the Gram-negative species (E. coliFluorescence (nm) Stokes shift (nm) FFa
691 9 0.14
687 10 0.17
687 10 0.19
687 10 0.09
702 9 0.30
691 11 0.23
1.0e3.0$106M.
Fig. 2. (a) Example of superposition of absorption and ﬂuorescence emission (lexc¼ 610 nm) spectra for 2a in DMSO; (b) Absorption, ﬂuorescence (lexc¼ 610 nm) and ﬂuorescence
excitation spectra of 2a in H2O.
Table 2
Singlet oxygen quantum yields (FD) determined in
DMSO.
Phthalocyanine FDa
2 0.56
2a 0.66
2b 0.72
2c 0.67
3 0.33
3a 0.32
a Std. FD (ZnPc)¼ 0.67 (DMSO) [64].
Table 3
Logarithm of partition coefﬁcients (log POW) of
metallophthalocyanines.
Phthalocyanine log POW
2a 3.45
2b 1.17
2c 0.56
3a 2.34
R.T. Aroso et al. / European Journal of Medicinal Chemistry 184 (2019) 111740 5and P. aeruginosa). Replacing Zn2þ by Al(OH)2þ in 2a versus 3a
lowers the uptake signiﬁcantly. The uptake of 2c is more complex
but its 8 positive charges do not bring an advantage relative to the 4Fig. 3. Detection of reactive oxygen species in biological medium using various ROS prob
presence of: (a) 3’-(p-Aminophenyl) ﬂuorescein (APF), (b) 3’-(p-Hydroxyphenyl) ﬂuorescei
interpretation of the references to colour in this ﬁgure legend, the reader is referred to thepositive charges of 2a.
Photodynamic inactivation of microorganisms. PDI with
cationic photosensitizers was evaluated against Gram-positive
bacteria, Gram-negative bacteria and fungi (Fig. 5aee). Inactiva-
tion with Zn(II) phthalocyanines was more pronounced towardses (25 mM) by irradiation of cationic phthalocyanines (10 mM) with white light in the
n (HPF), (c) singlet oxygen sensor green (SOSG) and (d) dihydroethidium (DHE). (For
Web version of this article.)
Fig. 4. Uptake of cationic phthalocyanines 2a, 2b, 2c and 3a: (a) E. coli, (b) P. aeruginosa, (c) S. aureus, (d) E. faecalis, (e) C. albicans.
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enabling a 7 logs reduction in both E. coli and P. aeruginosa at the
lowest concentration tested (100 nM). This is a remarkable PDI ef-
ﬁcacy in view of the resistance of Gram-negative bacteria
acknowledged in the literature. In fact, it exceeds the 6-log units
reduction efﬁciency targeted in FDA guidelines to ensure a high
level of disinfection [70]. The inactivation of Gram-positive bacteria
was less noteworthy. However, Al(III) phthalocyanine 3a proved
effective against S. aureus although its uptake is particularly low. In
fact, we did not ﬁnd a correlation between uptake and PDI efﬁcacy
in this series of photosensitizers: the much higher uptake of the
more lipophilic phthalocyanine 2b did not translate into higher PDI
efﬁcacy. A different view was offered in the literature using a series
of zinc porphyrins [56]. Our results advise against using uptake as a
surrogate of PDI efﬁcacy. Phthalocyanine 2b has the highest uptake
and the highest singlet oxygen quantum yield in DMSO but is less
phototoxic than phthalocyanine 2a.
It is common to report the potency of antibiotics in terms of
their minimal inhibitory concentration (MIC). This is less mean-
ingful in PDI because the ability to kill microorganisms comes from
the drug and light doses rather than the drug dose alone. Moreover,the effective light dose depends on the overlap between the
spectrum of the light source and the absorption spectrum of the
photosensitizers [71]. In view of these limitations, the MIC values
reported in Table 4 must be regarded with caution. Nevertheless, it
is shown show that MIC values for 2a are as low as those of potent
antibiotics.
Various promising photosensitizers for PDI of bacteria and fungi
have been reported [7,54,72,73]. Such reports showed that Gram-
positive bacteria more susceptible to PDI because their cell wall is
more permeable [25]. Fig. 5 shows that 2a is noteworthy for its
higher phototoxic towards Gram-negative bacteria, although it is
also very phototoxic to Gram-positive bacteria. This opens new
perspectives in the design of novel photosensitizers active against
multiple microorganisms. Clinical applications will favour the use
of a single photosensitizer that can kill both classes of bacteria,
allowing PDI without prior identiﬁcation of the cause of infectious
disease [74]. It is tempting to assign the notable efﬁcacy of 3a
against S. aureus to its ability to oxidize DHE. We speculate that
some vital structures in S. aureus are sensitive to oxidation by the
same mechanism as the oxidation of DHE.
Our PDI protocol relies on both soluble and cell bound
Fig. 5. Photoinactivation of bacteria and fungi irradiated with a light dose of 10 J/cm2: (a) E. coli, (b) P. aeruginosa, (c) S. aureus, (d) E. faecalis, (e) C. albicans.
Table 4
MIC values of investigated phthalocyanines determined for a light dose of 10 J/cm2.
Microorganism MIC [mg/mL]
2a 2b 2c 3a
E. coli 0.13 15 nd nd
P. aeruginosa 0.13 15 218 nd
S. aureus nd nd nd 106
C. albicans 1.4 31 nd nd
nd e not determined.
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ulations on PDI efﬁcacy was tested in a protocol including a
washing step to remove the unbound photosensitizer fraction. A
marked decrease in the inactivation of all types of microbial cellswas observed for both 2a and 2b (Fig. 6). The photosensitizer does
not need to be internalized by the bacteria to contribute to PDI,
which explains the lack of correlation between uptake and PDI
efﬁcacy. In topical applications, which are the most likely to be
translated to the clinic because PDI is a local treatment, it is unlikely
that the treatment protocol needs to include a washing step after
the application of the topical formulation.
Intracellular imaging with CLSM. The microenvironment may
alter the ﬂuorescence intensity signal with the uptake of the
photosensitizer [68]. Therefore, to conﬁrm the intracellular accu-
mulation of phthalocyanines in Gram-positive bacteria (S. aureus),
Gram-negative bacteria (E. coli) and fungal yeast (C. albicans), we
performed confocal laser scanning microscopy (CLSM). Fig. 7aec
presents the images obtained for 2b, which exhibits the highest
accumulation in these microorganisms. All microorganisms became
Fig. 6. Photoinactivation of (a) E. coli, (b) S. aureus and (c) C. albicans with 2a and 2b phthalocyanines washed with PBS before irradiation. In all experiments a light dose of 10 J/cm2
was used.
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proves that these photosensitizers are not aggregated in the cells.
This can be best appreciated by inspection of the ﬂuorescence
emission proﬁle along a cross section of a cell, as reported in Fig. 7d.
Similar results were obtained for the other phthalocyanines
(Figure 14, Data in Brief). The uptake by C. albicans (Fig. 7c) is at
similar level as those obtained E. coli and S. aureus, which is consis-
tent with Fig. 4. Confocal microscopy also enables spatially well-
deﬁned measurements inside the cells (z-stack, Fig. 7d), which
conﬁrm the presence of 2b inside the bacterial cells. It is worth to
highlight that these results were achieved without the addition of
membranedisruptors,whichmaybe added to improve uptake [8,11].
Dark cytotoxicity and photocytotoxicity against eukaryotic
cells. The viability of immortalized HaCaT (human keratinocyte)
cells was not signiﬁcantly affected by phthalocyanine concentra-
tions below 10 mM in the dark. Toxicity (~50% reduction in survival)
was only observed at the highest tested concentration of 100 mM
(Fig. 8a). Hence, these phthalocyanines have low cytotoxicity
against eukaryotic cells in the dark. When the phototoxicity of
cationic phthalocyanines against eukaryotic cells was evaluated
using the same PDT protocol as that used through this study to
assess PDI of bacteria and fungi, neither of tested compounds
showed signiﬁcant toxicity at 0.1 mM as determined in cell survival
MTT assay (Fig. 8b). The phototoxicity of all phthalocyanines
increased with concentration until ca. 10 mM, where it reached a
plateau of cellular viability. In the 0.1e5 mM concentration range, 3a
was the least cytotoxic, while 2c was more toxic to cells, particu-
larly at higher concentrations. Longer incubation times, more
typical of photodynamic therapy of cancer at long drug-to-light
intervals, led to slightly increased phototoxicity. This is related
with increased cellular uptake by HaCaT cells at longer incubation
times (from 2 h to 24 h).3. Conclusion
A new family of tetra-imidazolyl substituted metal-
lophthalocyanines was synthesized in high yields to evaluate
structure-activity relationships in PDI of bacteria and fungi. Three
structural motifs were investigated: size of cationizing alkyl chain,
degree of cationization and central diamagnetic metal. Cationic
Zn(II) metallophthalocyanines were found to have high molar ab-
sorption coefﬁcients (2.4<ε< 2.8 in units of 105M1 cm1) and high
singlet oxygen quantum yields (0.66<FD<0.72). Zn(II) tetra-ethyl
cationic phthalocyanine 2a showed the highest PDI efﬁcacy
against Gram-negative bacteria and C. albicans, with a 6 logs
reduction of their viability at photosensitizer concentrations as lowas 100 nM and 1 mM, respectively. These cationic photosensitizers
have low toxicity towards human keratinocytes (HaCaT cell line) at
concentrations effective in killing Gram-negative bacteria. The
selectivity of cationic phthalocyanines towards inactivation of
Gram-negative bacteria rather than for PDT of eukaryotic cells was
already noted by other authors [43,75], and is possibly related to
the higher number of anionic biomolecules present at the surface of
Gram-negative bacteria. The photosensitizers do not need to be
internalized by the bacteria to photoinactivate them, at least when
singlet oxygen is the predominant ROS.
A larger number of positive charges in the photosensitizer (8 vs.
4) does not necessarily improve PDI of Gram-negative bacteria. The
higher water solubility acquired with many charges may diminish
the interaction with bacteria. A higher lipophilicity will improve
uptake but not necessarily impact on efﬁcacy, especially when PDI is
performedwithout previouslywashing the cells to remove unbound
or electrostatically attached photosensitizer molecules. The success
with Zn(II) tetra-ethyl cationic phthalocyanine 2a results from a
moderate number of positive charges, a short alkyl chain, a metal
cation that favours intersystem crossing to the triplet state and no
low-lying charge-transfer states, and high singlet oxygen quantum
yield. Photosensitizer 2a is a good lead to PDI of topical infections.
4. Experimental section
Materials and equipment. All solvents were dried according to
standard procedures. Commercial reagents were from Sigma-
Aldrich and Fluorochem and were used without further puriﬁca-
tion. UVevis spectrawere recorded on Hitachi U-2001 or Shimadzu
2100 spectrophotometers. Nuclear magnetic resonance 1H and 13C
spectra were recorded on 400 Bruker Avance spectrometer (400
and 101MHz, respectively), using tetramethylsilane (d¼ 0.00 ppm)
as internal standard. The EI and ESI mass spectra were acquired
using a Autospec Micromass and Bruker Microtof, respectively.
Fluorescence spectra were obtained in a Horiba Jobin Yvon e Spex
Fluorolog 3.22. For determination of singlet oxygen quantum yields
excitation with the third harmonics of a Spectra-Physics Quanta-
Ray GCR-130 NdeYAG laser was used. Singlet oxygen phospho-
rescence was collected at 1270 nm using a Hamamatsu R5509-42
photomultiplier cooled to 193 K in a liquid nitrogen chamber [76].
5. Synthesis
5.1. 4-(10H-imidazol-10-yl)phthalonitrile (1)
Imidazole (1.26 g, 18.5mmol) was added to a solution of 4-
Fig. 7. Confocal laser scanning microscopy images of (a) E. coli, (b) S. aureus, (c)
C. albicans after incubation with 10 mM of cationic phthalocyanine 2b showing trans-
mitted light differential interference contrast images, living bacteria stained with
Hoechst, accumulation of PS in bacteria (red ﬂuorescence), merged images that show
localization of photosensitizer and the images registered at higher zoom (bottom
panels); (d) Sectioning (Z-stack) images at different focal planes that visualize the
intracellular accumulation of PS in bacteria cells. (For interpretation of the references
to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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in DMF (38ml). The reaction mixture was left at room temperature
for 48 h. The base was ﬁltered and the ﬁltrate was washed with a
small amount of DMF. The reaction mixturewas added to a mixture
of water and ice (200ml) and the yellow precipitate was ﬁltered. To
the precipitate, methanol (50ml) was added and the mixture was
heated with vigorous stirring. After cooling, the light-yellow pre-
cipitate was ﬁltered. Yield: 1.59 g (56%). 1H NMR (400MHz,
DMSO‑d6): d¼ 8.58 (d, J ¼ 1.7 Hz, 1H, H3); 8.53 (s, 1H, H20);
8.29e8.22 (m, 2H, H5þH6); 7.98 (s, 1H, H50); 7.18 (s, 1H, H40). 13C
NMR (101MHz, DMSO‑d6): d ¼ 140.23 (C4); 136.00 (C20); 135.70
(C6); 130.92 (C40); 124.44 (C3); 124.02 (C5); 117.60 (C5’); 116.44
(C1); 115.61 (C1eCN); 115.39 (C2eCN); 111.67 (C2). MS (EI): Calc.
194.0592; Found: 194.0591 [M]þ.
5.2. 2(3),9(10),16(17),23(24)-tetrakis(10H-imidazol-10-yl)
phthalocyanato zinc (II) (2)
A mixture of 4-(10H-imidazol-10-yl)phthalonitrile (1) (502mg,
2.58mmol) and Zn(OAc)2.2H2O (284mg, 1.29mmol) was reﬂuxed
in DMAE (4ml) for 48 h in inert atmosphere. After cooling, the
product was precipitated by addition of a mixture of methanol and
water and ﬁltered. The green precipitate was washed with 25ml of
water, methanol, acetone and dichloromethane. Yield: 385mg
(71%). UVeVis (DMSO): l, nm (log ε, M1 cm1): 358 (4.40); 616
(4.11); 682 (4.85). 1H NMR (400MHz, Pyridine-d5, 80 C): d
¼ 9.41e9.24 (m, 8H); 8.91e8.83 (m, 4H); 8.31e8.06 (m, 8H); 7.76 (d,
J ¼ 10.3 Hz, 4H). MS (ESI-TOF): Calc. 841.1740 Found: 841.1735
[MþH]þ.
5.3. 2(3),9(10),16(17),23(24)-tetrakis(30-ethyl-10H-imidazol-10-yl)
phthalocyanato zinc (II) iodide (2a)
Phthalocyanine 2 (100mg, 0.119mmol) and iodoethane (1ml,
12mmol) were dissolved in DMF (4ml). The reaction proceeded at
75 C for 48 h in inert atmosphere and an additional 3ml (36mmol)
of iodoethane was added during this period. The product was
precipitated with the addition of 40ml DCM and ﬁltered. Yield:
85mg (49%). UVeVis (DMSO): l, nm (log ε, M1 cm1): 354 (4.87);
611 (4.64); 677 (5.45). 1H NMR (400MHz, DMSO‑d6): d
¼ 10.50e10.10 (m, 4H); 9.80e9.05 (m, 4H); 9.00e8.50 (m, 8H);
8.44e8.08 (m, 8H); 4.45 (br, 8H); 1.62 (br, 12H). MS (ESI-TOF): Calc.
1337.0344 Found: 1337.0397 [M I]þ.
5.4. 2(3),9(10),16(17),23(24)-tetrakis(3’octyl-10H-imidazol-10-yl)
phthalocyanato zinc (II) iodide (2b)
Phthalocyanine 2 (150mg, 0.18mmol) and iodooctane (0.3ml,
1.8mmol) were dissolved in DMF (5ml). The reaction proceeded at
100 C for 48 h in inert atmosphere and an additional 0.3ml
(1.8mmol) of iodooctane were added during this period. After
cooling, 20ml of methanol were added and the product was
precipitated by 150ml of Et2O. Yield: 128mg (40%). UVeVis
(DMSO): l, nm (log ε, M1 cm1): 354 (4.79); 611 (4.57); 677
(5.38). 1H NMR (400MHz, DMSO‑d6): d ¼ 10.90e10.00 (m, 4H);
9.90e8.75 (m, 10H); 8.67e8.00 (m, 10H); 4.65e4.15 (m, 8H);
2.30e2.20 (m, 8H); 1.60e1.11 (m, 40H); 0.95e0.75 (m, 12H). MS
(ESI-TOF): Calc. 1546.5050 Found: 1546.5058 [M 2I]þ.
5.5. 2(3),9(10),16(17),23(24)-tetrakis(3’-(200-
ethyltrimethylammonium)-10H-imidazol-10-yl)phthalocyanato zinc
(II) iodide (2c)
Phthalocyanine 2 (166mg, 0.20mmol), (2-chloroethyl)trime-
thylammonium chloride (322mg, 2.10mmol) and KI (3.5 g,
Fig. 8. Cytotoxicity of 2a-2c and 3a phthalocyanines against human keratinocyte (HaCaT) cells. (a) Dark cytotoxicity. (b) Photocytotoxicity determined for various concentrations
after irradiation with white light at 10 J/cm2 under the conditions of PDI of bacteria.
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120 C for 72 h in inert atmosphere. After cooling, dichloromethane
(30ml) was added. The precipitate was washed with ethanol
(4 20 ml) using ultrasounds and ﬁltered. The resulting solid was
dissolved in H2O and was subjected to a size exclusion chroma-
tography using Sephadex® G-10 with a ﬂow rate of 2.5ml/min.
Yield: 125mg (42%). UVeVis (DMSO): l, nm (log ε, M1 cm1): 343
(4.74); 612 (4.56); 677 (5.41). 1H NMR (400MHz, DMSO‑d6): d
¼ 10.78 (br, 2H); 10.40 (br, 2H); 10.00e9.25 (br, 8H); 8.96e8.20 (m,
16H); 5.16 (br, 4H); 4.17 (m, 12H). Anal. Calcd. for C64H76I8N20Zn.4
KI: C 26.79; H 2.64; N 9.76%. Found: C 26.88; H 2.64; N 8.76%.5.6. 2(3),9(10),16(17),23(24)-tetrakis(10H-imidazol-10-yl)
phthalocyanato hydroxyaluminium (III) (3)
A mixture of 4-(10H-imidazol-10-yl)phthalonitrile (1) (500mg,
2.57mmol) and AlCl3 (171mg, 1.28mmol) was heated to 240 C in
1-chloronaphthalene (5ml) for 7 h, under inert atmosphere. After
cooling, the product was precipitated by addition of dichloro-
methane and ﬁltered-off. The green precipitate was washed with
25ml of acetone, water, acetone and ﬁnally dichloromethane.
Yield: 340mg (60%). UVeVis (DMSO): l, nm (log ε, M1 cm1): 364
(4.85); 624 (4.54); 693 (5.26). 1H NMR (400MHz, DMSO‑d6):
d ¼ 10.00 (s, 4H); 9.82 (m, 4H); 9.29 (m, 4H); 8.88 (m, 4H); 8.55 (m,
4H); 7.60 (s, 4H). MS (ESI-TOF): Calc. 821,2291 Found: 821.2285
[MþH]þ.5.7. 2(3),9(10),16(17),23(24)-tetrakis(30-ethyl-10H-imidazol-10-yl)
phthalocyanato hydroxyaluminium (III) iodide (3a)
Phthalocyanine 3 (120mg, 0.14mmol) and iodoethane (1ml,
12mmol) were dissolved in DMF (4ml). The reaction proceeded at
75 C for 48 h under inert atmosphere and an additional 3ml
(36mmol) of iodoethane were added during this period. The
product was precipitated with the addition of 20ml DCM and
ﬁltered. Yield: 155mg (79%). UVeVis (DMSO): l, nm (log ε, M1
cm1): 357 (4.85); 616 (4.48); 680 (5.23). 1H NMR (400MHz,
DMSO‑d6): d ¼ 10.55 (m, 4H); 10.33e10.21 (m, 4H); 9.99 (m, 4H);
8.98 (m, 8H); 8.37 (s, 4H); 4.54 (q, J¼ 7.3 Hz, 8H); 1.73 (t, J¼ 7.3 Hz,
12H). MS (ESI-TOF): Calc. 1061.2660 Found: 1061.2698 [M-3Ie2H]þ.
Molar absorption coefﬁcients. Molar absorption coefﬁcients
were determined according to Beer-Lambert’s law. For each com-
pound, a minimum of 6 solutions were prepared in concentrations
ranging from 107 to 106M corresponding to absorbance values
between 0.1 and 1.2.Fluorescence quantum yield. Fluorescence quantum yields
(FF) were determined in DMSO using a comparative method, ac-
cording to equation (1):
FF¼FStdF
FAStdh2
FStdAhStd2
(1)
where F and FStd are the integrals of the ﬂuorescence emission
curves of the samples and the standard, respectively; A and AStd are
the respective absorbances of the samples and standard at the
excitation wavelengths, respectively; h2 and h2Std are the refractive
indices of solvents used for the sample and standard, respectively.
Unsubstituted Zinc(II) phthalocyanine (ZnPc) in DMSO (FF¼ 0.18)64
was used as a standard. The absorbance of tested solutions at the
excitation wavelength (610e630 nm) ranged between 0.03 and
0.05, which corresponded to concentrations in the range of
1.0e3.0$106M.
Singlet oxygen quantum yield. Singlet oxygen quantum yields
(FD) were determined in DMSO using a comparative method and
direct measurement of singlet oxygen phosphorescence at
1270 nm. Decay curves of the singlet molecular oxygen emission
were extrapolated to time-zero for the reference (ZnPc, FD
Std¼ 0.67)64 and for the samples to obtain a relation between
emission intensities at a given laser power. This relation is identical
to the relation between the singlet molecular oxygen quantum
yields. The actual singlet oxygen quantum yields were obtained by
comparing the linear dependence between and the energy of the
laser pulse for the sample (S) and the reference (SStd) using (2):
FD¼FStdD
S
1 10A 
1 10AStd
SStd
(2)
where A and AStd are the absorbance of the sample and the refer-
ence, respectively.
Detection of reactive oxygen species in solution. 30-p-(ami-
nophenyl)ﬂuorescein (APF) and 30-p-(hydroxyphenyl)ﬂuorescein
(HPF) were used to detect hydroxyl radicals. Singlet Oxygen Sensor
Green® (SOSG) was used to probe for singlet oxygen. Dihy-
droethidinum (DHE) was used to identify the superoxide ion. The
probes were employed for the detection of ROS after illumination of
the photosensitizer. PS solutions were diluted to a ﬁnal concen-
tration of 10 mMper well. Tested ﬂuorescent probes were added at a
ﬁnal concentration of 15 mM. Photosensitizer’s solutions were
irradiated with white light using a 150W ﬁber optical illuminator
(OSH150) light for various time intervals. A microplate reader
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cence signal immediately before and after illumination. For APF
ﬂuorescence emission at 515 nm was determined upon excitation
at 490 nm. For SOSG, the corresponding values were 525 and
505 nm, and 480 nm and 580 nm for DHE.
Log POW determination. The n-octanol/PBS partition co-
efﬁcients (logP) were measured following shake-ﬂask method with
minor modiﬁcations as describe before. The photosensitizers were
dissolved in the mixture of n-octanol previously saturated with a
solution of PBS and the same volume of PBS saturated with n-
octanol. After addition of the samples of each phthalocyanine the
solutions were mixed on a vortex device and then the phases were
separated by centrifugation (15min, 8000 rpm, RT). Next, the PBS/
n-octanol phase was taken and diluted to obtain 0.5% of PBS/n-
octanol content in the ﬁnal solution. This solution was left into the
ultrasonic bath. The ﬂuorescence of each solution was measured
using Fluorescence Spectrometer LS 55 (PerkinElmer) and
compared with calibration curve to obtain the concentration of the
photosensitizer. Partition coefﬁcients were calculated from the ra-
tio coct/cPBS, where coct and cPBS are the concentrations of the
porphyrin derivatives in the n-octanol and in the PBS.
Binding of photosensitizer to microorganisms e uptake
studies. The microorganisms were incubated in suspension with
phthalocyanines (10 mM) for selected intervals (10e120min) in the
dark at RT. Unbound photosensitizer was removed by washing
twice in PBS without Ca2þ and Mg2þ. After the second wash the
cells were lysed in 10% SDS for 24 h. The cellular uptake of the
photosensitizer was evaluated by determination of ﬂuorescence
using excitation at Soret band (ca. 340e360 nm) and emission be-
tween 600 and 750 nm (Tecan Inﬁnite M200 Reader). Calibration
curves were prepared in 10% SDS and used for determination of PS
concentration. Uptake values were obtained by dividing the PS
concentration by the number of CFU. The number of molecules per
cell was calculated from concentration.
Photoinactivation of microorganisms. Both Gram-positive
bacteria (S. aureus, E. faecalis) and Gram-negative bacteria (E. coli
and P. aeruginosa) were used in this study. E. coli, P. aeruginosa and
E. faecalis were cultured in LB Broth/Lennox (BioShop Lab Science
Products), while S. aureus was grown in Brain Heart Infusion (BHI)
broth (Sigma Aldrich) in an orbital incubator (37 C, 130 rpm), until
the absorbance reached 0.5, which corresponded to approximately
107 CFU per mL. C. albicans were cultured overnight in YPD Broth
(BioShop) with aeration at 30 C reaching ca. 106 CFU/mL. Tested
microorganisms were incubated with various concentrations of the
phthalocyanines at pH 7.4 (PBS) for 1e2 h in the dark at room
temperature. Aliquots (1mL) were transferred to a 12-well plate
and illuminated with white light (using a 150W ﬁber optical illu-
minator (OSH150)). After illumination (or dark incubation - con-
trol) samples were mixed, serial-diluted in PBS and plated (LB agar)
to determine the number of CFU. Cells treated only with light (no
photosensitizer) were as viable as untreated cells (data not shown).
The viability was also monitored using LIVE/DEAD BacLight Bacte-
rial Viability Kit (Invitrogen; monitors membrane integrity) ac-
cording to manufacturer’s instructions.
Laser scanning confocal microscopy (LSCM) imaging. The
accumulation of cationic phthalocyanines in microorganisms was
followed with confocal imaging using a Zeiss LSM880 laser-
scanning microscope equipped with an argon ion laser. The
objective usedwas awater immersion ‘dipping’ lens (63x, Carl Zeiss
Ltd.) with a working distance of 1.46mm. Selected bacteria or fungi
cells were incubated with the phthalocyanine for an appropriate
time interval determined in uptake studies. After washing, the
microorganism cells were placed on the microscopic glass slides
and imaged. The separation between focal planes in Z-stack images
was 0.25 mm. Registered images were analysed with the Zeiss ZENsoftware.
Mammalian cell-based assays. Human keratinocytes (HaCaT)
were cultured in DMEM (BioTech) with addition of 10% foetal
bovine serum (BioTech, Poland) and supplemented with 1% anti-
biotics (penicillin/streptomycin). For experiments the cells were
removed by trypsinization, washed with PBS and maintained in a
humidiﬁed atmosphere at 37 C and 5% CO2.
Cytotoxicity in the dark. HaCaT cells were seeded in 96 well
plates (104 per well) and after attachment photosensitizer was
added in Hanks Balanced Salt Saline (DMSO<0.5%) at concentra-
tions between 0 and 100 mM. Cells were incubated for 2 h or 24 h at
37 C in the dark. Photosensitizer was removed, cells were washed
in PBS with Ca2þ and Mg2þ and 200 ml fresh culture medium sup-
plemented with FBS and antibiotics was added to each well. After
24 h cell viability was determined by MTT assay. Brieﬂy, MTT was
dissolved at 5mg/ml in PBS and added to each well at 0.5mg/ml.
After 3e4 h incubation the medium was discarded and 100 ml of
DMSO/methanol (1:1) was added to dissolve the dark blue crystals
of formazan. Formazan quantiﬁcation was performed using an
automatic microplate reader (Tecan Inﬁnite M200 Reader) by
absorbance measurements at 565 nm. Experiments were per-
formed in triplicates. Data are expressed as mean absorbance value
of six samples obtained in each independent experiments and
standard error of the mean.
Photodynamic effect. The cells were incubated in the darkwith
photosensitizer (0.1e100 mM) in HBSS for 2 h or 24 h and irradiated
with 10 J/cm2 white light using a 150W ﬁber optical illuminator
(OSH150). Following irradiation, the cells were washed with fresh
medium and plates were returned to the incubator. Cell viability
was determined by MTT viability assay (see above) 24 h after
irradiation.
Statistics. All values are expressed as average± SEM (standard
error of the mean), which represents the standard deviation of the
sample mean estimate of a population mean. All experiments were
repeated at least three times with comparable results. The sample
size in biological tests was N¼ 6e12 in each experimental group.
Experiments were also repeated at least three times with compa-
rable results. The t-test was used for the determination of statistical
signiﬁcance. Results were considered as statistically signiﬁcant
with a conﬁdence level of 95% (p< 0.05). Statistical analysis was
performed with the STATISTICA 12.5 (StatSoft Poland, Krakow).
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